Eton Pharmaceuticals, Inc. (ETON) Q4 2024 Annual Earnings
ETON·Reported March 18, 2025·Before market open
Eton Pharmaceuticals, Inc. reported Q4 2024 revenue of $11.6M, missed analyst consensus of $14.3M by $2.7M. Diluted EPS came in at $-0.02.
Revenue
$11.6Mmissed by $2.7M
Consensus: $14.3MDiluted EPS
$-0.02met estimate
Consensus: $-0.02
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Eton Pharmaceuticals, Inc.'s Q4 2024 earnings report.
Eton Pharmaceuticals, Inc. (ETON) reported Q4 2024 earnings on March 18, 2025 before market open.
Eton Pharmaceuticals, Inc. reported revenue of $11.6M and diluted EPS of $-0.02 for Q4 2024.
Revenue missed the consensus estimate of $14.3M by $2.7M. EPS beat the consensus estimate of $-0.02 by $0.00.
You can read the 10-K periodic report (0001437749-25-008136) directly on SEC EDGAR. The filing index links above go to sec.gov.